QUOTE AND NEWS
Market Intelligence Center  May 8  Comment 
AmSurg Corp. (NASDAQ: AMSG) closed Tuesday's trading session at $35.09. In the past year, the stock has hit a 52-week low of $25.00 and 52-week high of $35.09. AmSurg (AMSG) stock has been showing support around $34.52 and resistance in the $35.38...
StreetInsider.com  Apr 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Amsurg+Corp+%28AMSG%29+Tops+Q1+EPS+by+4c/8272719.html for the full story.
TheStreet.com  Mar 15  Comment 
NEW YORK (F.A.S.T. Graphs) -- Affordable health care is a huge problem for America, and the jury is still out on whether the Affordable Healthcare Act, aka, Obamacare is a blessing or curse. Regardless, I believe AmSurg Corp is part of the...
Benzinga  Feb 26  Comment 
Piper Jaffray maintained AmSurg (NASDAQ: AMSG) with a Neutral rating and raised the price target from $30.00 to $32.00. Piper Jaffray commented, "We expect AMSG to trade down on mixed Q4 results and FY13 EPS guidance that was lower than Street...
StreetInsider.com  Feb 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Amsurg+Corp+%28AMSG%29+Misses+Q4+EPS+by+2c%3B+Issues+Mixed+Outlook/8129558.html for the full story.
Stock Blog Hub  Dec 23  Comment 
We have reiterated our Neutral recommendation on AmSurg Corporation (AMSG) with a target price of $31.00. Even amid headwinds like reimbursement issues, higher expenses and economic uncertainty, AmSurg reported earnings per share ("EPS") of 49...
Benzinga  Jul 25  Comment 
Jefferies lowered its rating on AmSurg (NASDAQ: AMSG) from Buy to Hold and reduced its price target from $31 to $27. Jefferies commented, "We have serious concerns about AMSG's ability to hold its expensive 9x EBITDA multiple without a...
Benzinga  Jul 25  Comment 
Jefferies downgraded AmSurg (NASDAQ: AMSG) from “buy” to “hold.” AMSG's shares closed at $29.70 yesterday. AMSG's PEG ratio is 1.48. Analysts at Deutsche Bank downgraded CH Robinson Worldwide (NASDAQ: CHRW) from “buy” to “hold.”...
StreetInsider.com  Jul 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Amsurg+Corp+%28AMSG%29+Tops+Q2+EPS+by+1c%3B+Reaffirms+Outlook/7600508.html for the full story.
Marketwire  May 14  Comment 
HONG KONG -- (Marketwire) -- 05/14/12 -- Today, www.BollingerReport.com introduced featured coverage of Amsurg Corp (NASDAQ: AMSG) and Community Health Systems (NYSE: CYH). Full research reports are available to readers at:




RELATED WIKI ARTICLES
 

AmSurg Corporation (NASDAQ:AMSG) is a hospital operator that owns surgical centers throughout the U.S. As of December 31, 2009 AMSG had 202 ambulatory surgical centers in 32 states, and one center under development.[1] These centers focus almost exclusively on gastroenterology (studies of intestines) and ophthalmology (studies of eyes), which have higher proportions of senior patients than other specialties. Because of this, AmSurg is positioned to benefit from the aging of the US population - the number of US residents over 65 years old is growing so swiftly that it is on pace to double in the next 32 years.

Ambulatory surgical centers (ASCs) are healthcare facilities that specialize in providing surgical, pain management and diagnostic procedures in an outpatient setting.[2]AmSurg is the largest US operator of ASCs, holding 3.6% of the market by volume.[3] AmSurg is the only operator of ASCs to focus on gastroenterology and opthamology. Its primary competitors are hospitals located close to its facilities; like other operators of ambulatory surgical centers, the firm benefits from lower overhead because its centers do not provide services such as emergency care and intensive care units, which account for much of the overhead in traditional hospitals.

Lower costs allow ASCs to charge patients lower prices than hospitals for identical procedures, leading insurers to encourage their policyholders to choose its facilities.[4] For instance, the Medicare program saves approximately $464 million each year due to the utilization of ASCs by its beneficiaries; patients benefit as well - a procedure in an ASC can save as much as 61% in patient copayments.[5]

Company Overview

AmSurg acquires and develops ambulatory surgical centers in partnership with physicians, typically retaining a 51% or higher majority ownership stake in the facilities. Most of the firm's ASCs are single-specialty sites located inside or adjacent to a physician group practice and performing a limited array of high-volume, low-risk, outpatient surgical procedures, such as colonoscopies and cataract surgeries.

AmSurg receives all of its revenues from the fees it charges patients for the procedures; these, in turn, are largely funded by third-party reimbursement programs such as government and private insurance.[6] The firm grows primarily through acquisitions, though it also develops new ASCs.

Business and Financial Metrics

In 2009, AMSG earned a total of $669 million in total revenues. This was a significant increase from its 2008 total revenues of $601 million. Unsurprisingly, this had a positive effect on AMSG's net income. Between 2008 and 2009, AMSG's net income increased from $47 million in 2008 to $171 million in 2009.[7]

Business Segments

AmSurg operates as one business segment, since its centers all carry out similar functions and are administered on a centralized basis. However, it is possible to distinguish among the firm's facilities based on each center's surgical sub-specialty. The majority fall into one of three areas: gastroenterology, ophthalmology, and orthopedics.

Gastroenterology

These centers perform colonoscopies and other endoscopy procedures.

Ophthalmology

Ophthalmology centers perform cataract procedures and retinal laser surgery.

This is a really cool prceojt. I've been interested in the proliferation of these prceojts that put cool but horribly presented data to use (and in fact I've been working on one myself), and it's great to have such a slick assemblage of them. I'm also impressed that you did your first rails app so quickly. Will check out heroku.

You get a lot of respect from me for writing these heflpul articles.

Competition

AmSurg is the largest operator of ambulatory surgical centers in the United States, and the only one focusing primarily on single-specialty centers in the areas of gastroenterology and ophthalmology. As such, its primary competitors are hospitals, where patients can get the same procedures that AmSurg's centers provide.

Approximately 65% of the 4900 total ambulatory surgery centers are single specialty; among these, approximately 2,000 operate in one of the same specialties as AmSurg's centers. The industry is highly fragmented - no firm holds more than 4% of the market.

Market Share of Major ASC Operators, 2007
Market Share of Major ASC Operators, 2007[8] [9][10][11][12]
  • United Surgical Partners owns and operates 155 ambulatory surgery centers and surgical hospitals in two primary markets - the US and the United Kingdom. The firm has pursued partnerships with physicians for some of its centers.[13] In 2007, USP was acquired by private equity firm Welsh Carson. [14]
  • NovaMed (NOVA) has historically focused on operating single-specialty ophthalmic ASC performing primarily cataract surgeries. Over the past four years, however, the firm has taken steps to diversify its 34 centers into other specialties, ranging from plastic surgery to gynecology to orthopedics. Like AmSurg, NovaMed owns a majority interest in most of its centers, with physicians owning the rest. NovaMed also operates several smaller segments - manufacturing surgical equipment and operating optical laboratories, an optical products purchasing organization and a marketing products and services business.[15]
  • Symbion (SMBI) is headquartered in Nashville like AmSurg, and has a similar business model, though on a smaller scale - the firm owns 70 ambulatory surgery centers.[16] In 2007, the firm was bought out by private equity company Crestview Partners.[17]

This is a nice feature, but unuartfnotely it doesn't work in the latest version of SEOQuake (with FF 3.5). It ends up being a semi-colon delimited file instead of a comma delimited. It would sure be nice to have a quick fix to this currently, I just open up the CSV that SEOQuake and do a find and replace to replace all the  ;'s with ,'s.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki